Karen Gripp, Peter Krawitz
FDNA has appointed Karen Gripp as CMO and Peter Krawitz as chief data science officer. The maker of the Face2Gene suite of next-generation phenotyping (NGP) applications said in a statement that their combined clinical, research, and development experience "will elevate the use and proven success of NGP technologies that capture, structure, and interpret complex physiological information." Gripp is chief of medical genetics at the AI duPont Hospital for Children and a professor of pediatrics at the Sidney Kimmel Medical College at Thomas Jefferson University. Krawitz is director of the Institute for Genomic Statistics and Bioinformatics at the University of Bonn in Germany and has been working with FDNA on a study called Prioritization of Exome Data By Image Analysis, or PEDIA, to determine the impact of phenotype and facial analysis on molecular interpretation.